-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the latest announcement from the Center for Drug Evaluation (CDE) of the National Food and Drug Administration of China, the fourth-generation EGFR small molecule targeted drug FWD1509 independently developed by Fuwo Pharmaceutical has been approved for clinical use in China, and its indication is advanced non-small cell lung cancer ( NSCLC)
Image source: CDE screenshot